Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

Tapering Stress Dose Steroids

Initial Stress Dosing Protocol

  • For patients with severe stress or adrenal crisis, the American College of Clinical Oncology recommends starting with hydrocortisone 50-100 mg IV bolus, followed by hydrocortisone 50 mg IV/IM every 6 hours 1, 2, 3

Tapering Protocol

  • The American College of Clinical Oncology recommends tapering IV stress-dose steroids down to oral maintenance doses over 5-7 days once the patient is hemodynamically stable and vasopressors are no longer required 1, 2, 3
  • The Society of Critical Care Medicine suggests that tapering should be based on clinical status, such as vasopressor requirement and hemodynamic stability, rather than arbitrary time frames 4, 3

Maintenance Dosing After Taper

  • The American College of Clinical Oncology recommends a standard maintenance regimen of hydrocortisone 15-20 mg daily in divided doses 2, 5, 3
  • For patients with primary adrenal insufficiency, the Endocrine Society recommends adding fludrocortisone 0.05-0.1 mg/day for mineralocorticoid replacement 5, 3

Critical Pitfalls to Avoid

  • The Society of Critical Care Medicine warns against tapering abruptly, as it can lead to hemodynamic and immunologic rebound effects 4
  • The American College of Clinical Oncology advises against using fixed-duration protocols rigidly and instead recommends tapering based on clinical status 4, 3

Patient Education Requirements

  • The American College of Clinical Oncology recommends that all patients receive education on stress dosing for sick days, emergency injectable hydrocortisone kits, and medical alert bracelets/necklaces indicating adrenal insufficiency 2, 5, 3

Monitoring During Taper

  • The Endocrine Society recommends watching for signs of inadequate replacement, such as unexplained hypotension, fatigue, and hyponatremia 6
  • The American College of Clinical Oncology suggests considering endocrine consultation for recovery and weaning protocols in patients with symptoms of adrenal insufficiency after weaning off corticosteroids 2, 5